Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
347 Results Found
340B Advocacy Alliance Bulletin - September 30, 2025
In a letter responding to HRSA’s information collection request regarding the expected costs of its 340B Rebate Model Pilot Program, the AHA said 340B hospitals indicated that the operational costs associated with the rebate model could range from $150,000 to over $500,000 per hospital.
AHA Letter to HRSA Re: The 340B Rebate Model Pilot Program
AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.
AHA 340B Advocacy Alliance Bulletin - September 24, 2025
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges against the state’s law protecting 340B pricing for contract pharmacy arrangements.
AHA, Others Files Amicus Brief Against Novartis’ Motion to Block Maine’s 340B Contract Pharmacy Law
AHA, others file amicus brief opposing Novartis’ motion for preliminary injunction against enforcement of Maine’s 340B contract pharmacy law.
AHA, Others File Amicus Brief Against Abbvie’s Motion to Block Maine’s 340B Contract Pharmacy Law
AHA, others file amicus brief opposing AbbVie’s motion for preliminary injunction against enforcement of Maine’s 340B contract pharmacy law.
AHA 340B Advocacy Alliance Bulletin - September 16, 2025
AHA 340B Advocacy Alliance Bulletin - September 16, 2025.
AHA comments on CY 2026 OPPS proposed rule
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical center payment system proposed rule.
AHA Details Legislative Priorities for Congressional Leaders
Hospitals and health systems are experiencing significant financial pressures that challenge their ability to provide 24/7 care for the patients and communities they serve. As Congress begins to focus on its end-of-the-year work, America’s hospitals and health systems respectfully request that you consider the following priorities.
Appeals court upholds lower court denial of AbbVie’s preliminary injunction, preserving Mississippi 340B contract pharmacy law
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.